Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A embryonal carcinoma that involves the central nervous system.
Biomarker and diagnostic research for embryonal carcinoma of the central nervous system has been reported in the published literature.
No clinical trials have been registered for embryonal carcinoma of the central nervous system.
10 publications have been identified in PubMed for embryonal carcinoma of the central nervous system. Research spans Review / Meta-Analysis (50%), Basic Science / Preclinical (20%), and Diagnostic / Biomarker (10%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 5 | 50% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 4:37 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research
2 |
20% |
Testing and diagnosis research | 1 | 10% |
Patient case studies | 1 | 10% |
Clinical study results | 1 | 10% |
Faure Conter C (2026). [PMID: 42115464](https://pubmed.ncbi.nlm.nih.gov/42115464/). *Adv Tech Stand Neurosurg*. [Review / Meta-Analysis]
Janssen FW (2026). [PMID: 41998312](https://pubmed.ncbi.nlm.nih.gov/41998312/). *Commun Med (Lond)*. [Diagnostic / Biomarker]
Borlongan MC (2025). [PMID: 40272656](https://pubmed.ncbi.nlm.nih.gov/40272656/). *Discover oncology*. [Review / Meta-Analysis]
Guo Q (2025). [PMID: 40354951](https://pubmed.ncbi.nlm.nih.gov/40354951/). *International journal of radiation oncology, biology, physics*. [Review / Meta-Analysis]
Silva L (2025). [PMID: 40621458](https://pubmed.ncbi.nlm.nih.gov/40621458/). *Frontiers in immunology*. [Basic Science / Preclinical]
Takami H (2025). [PMID: 41198340](https://pubmed.ncbi.nlm.nih.gov/41198340/). *Advances in cancer research*. [Review / Meta-Analysis]
Abdulfatah E (2024). [PMID: 38697270](https://pubmed.ncbi.nlm.nih.gov/38697270/). *Human pathology*. [Clinical Trial Publication]
Sekar MD (2024). [PMID: 37853749](https://pubmed.ncbi.nlm.nih.gov/37853749/). *International journal of surgical pathology*. [Case Report / Case Series]
de Paula Silva N (2024). [PMID: 38915419](https://pubmed.ncbi.nlm.nih.gov/38915419/). *EJC paediatric oncology*. [Review / Meta-Analysis]
Wang H (2024). [PMID: 39526890](https://pubmed.ncbi.nlm.nih.gov/39526890/). *eLife*. [Basic Science / Preclinical]